期刊文献+

shRNA靶向干扰COX-2稳定细胞系的建立及鉴定

Construction and Identification of Cell Lines of COX-2 Inhibited by shRNA
原文传递
导出
摘要 脂质体法将COX-2-shRNA载体转染肝癌细胞株SMMC-7721,G418筛选获得稳定细胞系COX-2-shRNA-SMMC-7721,通过RT-PCR和Western blot分别检测细胞系中COX-2基因mRNA转录水平和蛋白质表达水平,通过MTT、流式细胞术和Transwell等观察细胞恶性生物学行为的改变。建立COX-2-shRNA-SMMC-7721(干扰组)、HK-SMMC-7721(阴性对照组)细胞株。干扰组的COX-2基因mRNA的转录水平、蛋白表达水平和细胞增殖能力较阴性对照组和SMMC-7721(空白组)明显下降(P<0.05),而阴性对照组与空白组间无明显差异(P>0.05);干扰组、阴性对照组和空白组处于G0/G1期的细胞分别为(68.85±0.27)%、(53.05±0.35)%和(53.54±0.33)%;细胞凋亡率分别为(9.60±0.20)%、(1.79±0.23)%和(1.75±0.20)%;穿膜细胞数分别为(117.60±5.30)、(338.40±11.50)和(347.40±12.80)个。干扰组与阴性对照组和空白组有显著差异(P<0.05),而阴性对照组与空白组间无明显差异(P>0.05)。利用RNA干扰技术成功构建了靶向干扰COX-2的稳定肝癌细胞系COX-2-shRNA-SMMC-7721,为COX-2分子的作用机制研究提供了细胞模型。 The constructed recombinant interference plasmid pshRNA-COX-2 was transfected into SMMC7721 cells by lipofectamine mediation, then monoclonal cell line was selected by G418 pressure. The expressions of COX-2 mRNA and protein were measured by reverse transcription polymerase chain reaction (RT-PCR) and Western blot respectively, and the changes of cell proliferation and apoptosis were assessed by MTT assay and flow cytometry, respectively. The Transwell test was used to detect the invasion ability of cell lines. COX-2-shRNA-SMMC-7721 (interference group), HK-SMMC-7721 group (negative control group) cell lines were established. The levels of interference group's COX-2 mRNA transcription, COX-2 protein expression and cell proliferation significantly decreased. There were significant differences compared with those of the control group and SMMC-7721 (blank group) (P〈0.05), while those of control group and blank control group were not significantly different (P〉0.05). Interference group, control group and blank group of cells in G0√G1 phase were (68.85±0.27)%, (53.05±0.35)% and (53.54±0.33)%, respectively; the percentage of apoptotic cells were (9.60±0.20)%, (1.79±0.23)% and (1.75±0.20)% separately; transmembrane cell number were (117.60±5.30), (338.40±11.50) and (347.40±12.80) cells, respectively. There were significant differences comparing interference group with control group and blank group (P〈O.05), while the controlgroup and blank control group were not significantly different (P〉0.05). The cell line COX-2-shRNA-SMMC-7721,in which COX-2 expression was inhibited using RNA interference technology, was successfully established, whichcould provide the cell model for fflrther study of C0X-2 gene function.
出处 《中国细胞生物学学报》 CAS CSCD 北大核心 2013年第6期774-779,共6页 Chinese Journal of Cell Biology
基金 国家自然科学基金面上项目(批准号:81172016)资助的课题~~
关键词 COX-2 SHRNA 稳定细胞系 肝癌 COX-2(cyclooxygenase-2) shRNA stable cell lines liver cancer
  • 相关文献

参考文献2

二级参考文献28

  • 1Melchiorre Cervello,Giuseppe Montalto.Cyclooxygenases in hepatocellular carcinoma[J].World Journal of Gastroenterology,2006,12(32):5113-5121. 被引量:25
  • 2Nishie A, Ono M, Shono T, Fukushi J, Otsubo M, Onoue H,Ito Y, Inamura T, Ikezaki K, Fukui M, Iwaki T, Kuwano M.Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res 1999; 5:1107-1113.
  • 3Davidson B, Goldberg I, Gotlieb WH, Lerner-Geva L, Ben-Baruch G, Agulansky L, Novikov I, Kopolovic J. Macrophage infiltration and angiogenesis in cervical squamous cell carcinoma - clinicopathologic correlation. Acta Obstet Gynecol Scand 1999; 78:240-244.
  • 4Ohta M, Kitadai Y, Tanaka S, Yoshihara M, Yasui W, Mukaida N, Haruma K, Chayama K. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas. Int J Cancer 2002; 102:220-224.
  • 5Tanaka M, Nakashima O, Wada Y, Kage M, Kojiro M. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology 1996; 24:807-812.
  • 6Bortolami M, Venturi C, Giacomelli L, Scalerta R, Bacchetti S, Marino F, Floreani A, Lise M, Naccarato R, Farinati F.Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer. Dig Liver Dis 2002; 34:794-801.
  • 7Ribatti D, Vacca A, Nico B, Crivellato E, Roncali L, Dammacco F. The role of mast cells in tumour angiogenesis. Br J Haematol 2001; 115:514-521.
  • 8Norrby K. Mast cells and angiogenesis. APMIS 2002; 110:355-371.
  • 9Hagmann W, Hacker HJ, Buchholz U. Resident mast cells are the main initiators of anaphylactic leukotriene production in the liver. HepatoloF~y 1992; 16:1477-1484.
  • 10Terada T, Matsunaga Y. Increased mast cells in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Hepatol 2000; 33:961-966.

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部